...
首页> 外文期刊>Journal of pharmacy practice >Anticoagulation in the Elderly
【24h】

Anticoagulation in the Elderly

机译:老年人抗凝

获取原文
获取原文并翻译 | 示例

摘要

Oral anticoagulation has been shown to provide great benefit in preventing and treating thromboembolic disorders. The challenges of oral anticoagulation management in the elderly involve balancing the risks of bleeding versus the benefits of a life-saving treatment. Due to the complex nature of warfarin, therapy must be individualized with frequent monitoring, reeducation, and adjustments based on concurrent illness and drug therapy. This review focuses on the use of warfarin, including indications, dosing recommendations, drug and dietary interactions, and reversal of anticoagulation. Methods to determine bleeding risks in this population and barriers that interfere with the prescribing of warfarin are discussed. Strategies to improve patient outcome and reduce adverse events are provided to assist clinicians in their decision-making skills. The potential advantages of anticoagulation clinics are summarized with regards to coordinating the care and minimizing the risks of anticoagulant therapy. The role of new-generation anticoagulants is also discussed as to their place in therapy.
机译:口服抗凝剂已显示出对预防和治疗血栓栓塞性疾病的巨大益处。老年人口服抗凝治疗的挑战包括平衡出血风险与挽救生命的益处。由于华法林的复杂性,必须根据经常发生的疾病和药物治疗,对治疗进行个体化,并进行频繁的监测,再教育和调整。这篇综述的重点是华法林的使用,包括适应症,给药建议,药物和饮食之间的相互作用以及抗凝作用的逆转。讨论了确定该人群出血风险的方法以及干扰华法令处方的障碍。提供了改善患者预后并减少不良事件的策略,以帮助临床医生进行决策。总结了抗凝诊所的潜在优势,以协调护理并最大程度地降低抗凝治疗的风险。还讨论了新一代抗凝剂在治疗中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号